Cite
Exploiting RIG-I-like receptor pathway for cancer immunotherapy.
MLA
Jiang, Yangfu, et al. “Exploiting RIG-I-like Receptor Pathway for Cancer Immunotherapy.” Journal of Hematology & Oncology, vol. 16, no. 1, Feb. 2023, pp. 1–27. EBSCOhost, https://doi.org/10.1186/s13045-023-01405-9.
APA
Jiang, Y., Zhang, H., Wang, J., Chen, J., Guo, Z., Liu, Y., & Hua, H. (2023). Exploiting RIG-I-like receptor pathway for cancer immunotherapy. Journal of Hematology & Oncology, 16(1), 1–27. https://doi.org/10.1186/s13045-023-01405-9
Chicago
Jiang, Yangfu, Hongying Zhang, Jiao Wang, Jinzhu Chen, Zeyu Guo, Yongliang Liu, and Hui Hua. 2023. “Exploiting RIG-I-like Receptor Pathway for Cancer Immunotherapy.” Journal of Hematology & Oncology 16 (1): 1–27. doi:10.1186/s13045-023-01405-9.